Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2007, p. 595-599, Vol. 45, No. 2
0095-1137/07/$08.00+0 doi:10.1128/JCM.01454-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Wadsworth Center, New York State Department of Health, Albany, New York,1 International Laboratory Branch, Global AIDS Program, Centers for Disease Control and Prevention, Atlanta, Georgia,2 University of Kinshasa Teaching Hospital, Kinshasa, Democratic Republic of Congo,3 Unité de la Tuberculose et des Mycobactéries, Institut Pasteur de Guadeloupe, Pointe-à-Pitre, Guadeloupe4
Received 13 July 2006/ Returned for modification 19 September 2006/ Accepted 20 November 2006
Testing for susceptibility to pyrazinamide (PZA) and analysis of the pncA gene sequences of 423 Mycobacterium tuberculosis complex isolates have revealed a unique silent nucleotide substitution that enables the rapid identification of "M. canettii" (proposed name). Moreover, the lack of a defined mutation within the pncA gene strongly suggests that an alternative mechanism is responsible for PZA resistance. Our results indicate that DNA sequencing of the pncA gene has the potential to shorten the turnaround time and increase the accuracy of PZA susceptibility testing of the M. tuberculosis complex.
Published ahead of print on 29 November 2006.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»